Meet Amedica
Founded in Norway in 2014 by Linn Emilie, Amedica stands confidently as a champion of innovation in cosmetic aesthetics. Committed to identifying high-performance treatments and scientifically validated products, Amedica has evolved from a prominent distribution enterprise to a leading product development business within the global aesthetics market. Amedica’s global clientele has access to products of unparalleled quality, with optimal outcomes; a portfolio that assures the improvement of patients’ skin health.
Latest Innovation

The Ameela polynucleotide range is the latest innovation from Amedica. Ameela® is a viscoelastic, sterile, non-pyrogenic, absorbable intradermal injectable solution, based on polymerized polynucleotides. The polynucleotides used in Ameela® are purified, making them free from other components, such as proteins, which can trigger an immune response. It is an innovative and effective way to restore skin firmness and elasticity and ensure healthy skin that is protected against free radicals and cellular damage. The DNA is derived from existing farmed Salmon, meaning no Salmon is farmed especially for the creation of the treatment. www.AmeelaSkin.com

Following suit, their reputation as figureheads in the medical and cosmetic industry, Amedica is also a leading manufacturer for Nordyx, the best-in-class regenerative threads. https://www.nordyxthreads.com/